Valero A, Garrido E, Malet A, Estruch A, Gispert J, Rubio E
Centre D'estudis d'alt rendiment esportiu, Barcelona, Spain.
Allergol Immunopathol (Madr). 1996 Mar-Apr;24(2):81-6.
This open labelled, group comparative, cross over study, was carried out to analyze the efficacy of two dosages of Nedocromil sodium (NS) in the prophylaxis of Exercise Induced Asthma (EIA). 13 athletes (6 males, 7 females), aged: 12-38 years, were studied measuring their EIA by forced spirometries prior and at 1, 3, 5, 10, 15 and 30 minutes post treadmill test. Four mg of NS were administered via inhalation chamber 30 minutes prior to the second test; prior to the third one;: NS at a dose of 4 mg every 8 hours during four weeks plus 4 mg of NS 30 minutes before it. In the baseline exercise test, a 33.6 +/- 10.5 percent decrease of FEV1 was observed; 12.6 +/- 11.4 in the second one, and 9.7 +/- 9.76 in the third test. A protection index higher than 30% was obtained in 9 cases of the second test (81.5 +/- 16.2%), and in 10 of the third one (77.2 +/- 15.3%). Nedocromil sodium (4 mg prior to exercise) is effective for EIA prophylaxis. Although no significant differences exist between both dosages, a greater protection index is reached after NS sustained administration.
本开放性标签、组间比较、交叉研究旨在分析两种剂量的奈多罗米钠(NS)预防运动诱发性哮喘(EIA)的疗效。研究了13名年龄在12至38岁之间的运动员(6名男性,7名女性),通过在跑步机测试前以及测试后1、3、5、10、15和30分钟进行用力肺活量测定来评估他们的运动诱发性哮喘情况。在第二次测试前30分钟通过吸入室给予4毫克NS;在第三次测试前:在四周内每8小时给予4毫克NS,并且在测试前30分钟再给予4毫克NS。在基线运动测试中,观察到第一秒用力呼气量(FEV1)下降了33.6±10.5%;在第二次测试中下降了12.6±11.4%,在第三次测试中下降了9.7±9.76%。在第二次测试的9例中(81.5±16.2%)以及第三次测试的10例中(77.2±15.3%)获得了高于30%的保护指数。运动前给予4毫克奈多罗米钠对预防运动诱发性哮喘有效。虽然两种剂量之间没有显著差异,但在持续给予NS后可达到更高的保护指数。